foxo4 dri for senescent cells FOXO4-DRI: Human Trial Status, Cancer Research & Senolytic Data FOXO4-DRI
FOXO4 DRI FOXO4 DRI Peptide 10 mg Figure 5 FOXO4 DRI alleviates age related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice Aging FOXO4 DRI Research Peptide 15mg Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv
Pay in 4 interest-free payments of $7.06 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5




